ScoreComparison
Why is AngioDynamics, Inc. ?
1
Poor Management Efficiency with a low ROE of 2.80%
- The company has been able to generate a Return on Equity (avg) of 2.80% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate -0.28% of over the last 5 years
3
Positive results in Nov 25
- NET PROFIT(HY) Higher at USD -10.86 MM
- RAW MATERIAL COST(Y) Fallen by -3.54% (YoY)
- DEBTORS TURNOVER RATIO(HY) Highest at 7.02 times
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 10.28%, its profits have fallen by -47.9%
5
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to AngioDynamics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is AngioDynamics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
AngioDynamics, Inc.
13.45%
1.33
45.89%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.54%
EBIT Growth (5y)
-0.28%
EBIT to Interest (avg)
-19.60
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
1.40
Tax Ratio
0.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
2.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.52
EV to EBIT
-19.54
EV to EBITDA
124.25
EV to Capital Employed
2.96
EV to Sales
1.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-15.15%
ROE (Latest)
-8.98%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET PROFIT(HY)
Higher at USD -10.86 MM
RAW MATERIAL COST(Y)
Fallen by -3.54% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 7.02 times
OPERATING PROFIT(Q)
Highest at USD 3.26 MM
OPERATING PROFIT MARGIN(Q)
Highest at 4.1 %
-4What is not working for the Company
INTEREST(9M)
At USD 0.11 MM has Grown at inf%
Here's what is working for AngioDynamics, Inc.
Net Profit
Higher at USD -10.86 MM
than preceding 12 month period ended Nov 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Profit
Highest at USD 3.26 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 4.1 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Debtors Turnover Ratio
Highest at 7.02 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -3.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for AngioDynamics, Inc.
Interest
At USD 0.11 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
